Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Amantadine in influenza]

U Lassen¹, A Hornsleth

¹Lungemedicinsk afdeling P, og, Bispebjerg Hospital, København, Københavns Universitet, Institut for Medicinsk Mikrobiologi.

Ugeskrift for Laeger

|July 20, 1992

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of cergutuzumab amunaleukin: a phase I study in patients with advanced and/or metastatic solid tumors.

ESMO open·2026

Same author

A comprehensive assessment of the existing landscape of personalized cancer medicine in the European Union, on behalf of the PCM4EU consortium.

ESMO open·2025

Same author

Copenhagen Prospective Personalized Oncology (CoPPO)-impact of comprehensive genomic profiling in more than 2000 patients in a phase I setting.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Same author

Comprehensive analysis of failure to carry out successful genomic profiling in a phase I setting.

ESMO open·2024

Same author

Overcoming barriers in biomarker testing. Letter to the Editor regarding: 'ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe', by A. Bayle et al.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Same author

Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma.

Investigational new drugs·2019